Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP)
CUSIP: 45339J105
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 113,183,288
- Total 13F shares
- 602,239
- Share change
- +31,710
- Total reported value
- $1,058,915
- Price per share
- $1.76
- Number of holders
- 18
- Value change
- +$56,020
- Number of buys
- 8
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 45339J105?
CUSIP 45339J105 identifies INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45339J105:
Top shareholders of INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Glen R. Anderson |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,190,400
|
$2,785,536 | — | 10 Aug 2023 | |
| Hoonmo Lee |
3/4/5
|
Director |
—
mixed-class rows
|
708,272
mixed-class rows
|
$1,626,157 | — | 04 Aug 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.22%
|
250,748
|
$690,811 | — | 30 Sep 2023 | |
| INVESTMENT HOUSE LLC |
13F
|
Company |
0.09%
|
102,849
|
$283,349 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
54,767
|
$148,992 | — | 30 Sep 2023 | |
| STRATEGY ASSET MANAGERS LLC |
13F
|
Company |
0.04%
|
45,336
|
$124,901 | — | 30 Sep 2023 | |
| Pine Valley Investments Ltd Liability Co |
13F
|
Company |
0.04%
|
44,240
|
$121,882 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
24,400
|
$67,000 | — | 30 Sep 2023 | |
| Vivaldi Capital Management LP |
13F
|
Company |
0.02%
|
24,000
|
$66,120 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
19,473
|
$52,967 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,033
|
$8,356 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,029
|
$2,835 | — | 30 Sep 2023 | |
| Boyan Vesselinov Litchev |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
1,150
|
$2,691 | — | 01 Feb 2022 | |
| Bangor Savings Bank |
13F
|
Company |
0%
|
400
|
$1,102 | — | 30 Sep 2023 | |
| Brian O'Callaghan |
3/4/5
|
Director |
—
class O/S missing
|
13,750
|
$976 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
137
|
$377 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
102
|
$281 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
7
|
$19 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
7
|
$19 | — | 30 Sep 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Sep 2023 |
Institutional Holders of Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) as of Q4 2023
As of 31 Dec 2023,
Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
602,239 shares.
The largest 10 holders included
VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, Pine Valley Investments Ltd Liability Co, RENAISSANCE TECHNOLOGIES LLC, Vivaldi Capital Management LP, STATE STREET CORP, CITADEL ADVISORS LLC, and Tower Research Capital LLC (TRC).
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
16
Q4 2023 holders
18
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.